Anh Nguyen Duc
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 5
- Cancer Research top 5%
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 2
- Immunology top 10%
-
- Advanced Breast Cancer Therapies 5
-
- Monoclonal and Polyclonal Antibodies Research 2
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Luciana MolineroHiroji IwataJane Yuet Ching HuiCarlos H. BarriosMario Liste-HermosoShilpen PatelShigehira SajiNadia Harbeck
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Anh Nguyen Duc
14 papers receiving 918 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 797
- Cancer Research 361
- Immunology 239
- Pulmonary and Respiratory Medicine 237
- Pathology and Forensic Medicine 49
Countries citing papers authored by Anh Nguyen Duc
This map shows the geographic impact of Anh Nguyen Duc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anh Nguyen Duc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anh Nguyen Duc more than expected).
Fields of papers citing papers by Anh Nguyen Duc
This network shows the impact of papers produced by Anh Nguyen Duc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anh Nguyen Duc. The network helps show where Anh Nguyen Duc may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anh Nguyen Duc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 8 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 2 | |
| 8 | Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trialbreakdown → | 2020 | 718 |
| 9 | 2020 | 16 | |
| 10 | 2020 | 5 | |
| 11 | 2019 | 84 | |
| 12 | 2019 | 60 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 3 | |
| 15 | 2017 | 1 |
About Anh Nguyen Duc
Anh Nguyen Duc is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 925 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Genomics and Diagnostics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (797 citations), Cancer Research (361 citations) and Immunology (239 citations). Anh Nguyen Duc has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Luciana Molinero, Hiroji Iwata, Jane Yuet Ching Hui, Carlos H. Barrios, Mario Liste-Hermoso, Shilpen Patel, Shigehira Saji, Nadia Harbeck, Kyung Hae Jung and Roberto Hegg. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.